🇺🇸 Perindopril tablet in United States

57 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Malaise — 8 reports (14.04%)
  2. Dyspnoea — 7 reports (12.28%)
  3. Diarrhoea — 6 reports (10.53%)
  4. Rhabdomyolysis — 6 reports (10.53%)
  5. Abdominal Pain — 5 reports (8.77%)
  6. Acute Kidney Injury — 5 reports (8.77%)
  7. Angioedema — 5 reports (8.77%)
  8. Drug Interaction — 5 reports (8.77%)
  9. Hyponatraemia — 5 reports (8.77%)
  10. Nausea — 5 reports (8.77%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Perindopril tablet approved in United States?

Perindopril tablet does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Perindopril tablet in United States?

Pharmtechnology LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.